4UBI:XETRA:XETRA-UBS (Irl) ETF plc - MSCI USA Socially Responsible UCITS ETF (USD) A-acc (EUR)

ETF | Others |

Last Closing

USD 16.856

Change

+0.11 (+0.66)%

Market Cap

USD 0.37B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.56 (-1.12%)

USD 509.68B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.24 (-1.50%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.38 (-1.44%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.40 (-1.44%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.29 (-1.23%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.62 (-1.41%)

USD 101.50B
8R80:XETRA Amundi Index Solutions - Amund..

-1.12 (-0.79%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.73 (-1.44%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.92 (+0.17%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.33 (-1.50%)

USD 79.79B

ETFs Containing 4UBI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.82% 75% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.82% 75% C 74% C
Trailing 12 Months  
Capital Gain 20.16% 80% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.16% 79% B- 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.80% 66% D+ 64% D
Dividend Return 7.80% 65% D 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.55% 56% F 65% D
Risk Adjusted Return 67.50% 76% C+ 79% B-
Market Capitalization 0.37B 62% D 55% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike